- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
---|---|---|---|---|---|---|
Remibrutinib Field Medical Lead | Seoul | South Korea | International | Innovative Medicines | Research & Development | Jul 16, 2024 |
Regulatory Affairs Specialist | Seoul | South Korea | Development | Innovative Medicines | Research & Development | Jul 14, 2024 |
Clinical Project Manager | Seoul | South Korea | International | Innovative Medicines | Research & Development | Jul 11, 2024 |
RLT Health Care System Lead | Seoul | South Korea | International | Innovative Medicines | Sales | Jun 26, 2024 |
TX Product Manager | Seoul | South Korea | International | Innovative Medicines | Marketing | Jun 26, 2024 |
PNH Field Medical Lead | Seoul | South Korea | International | Innovative Medicines | Research & Development | Jun 09, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى